Article info
Letter
High oligoclonality of immunoglobulins in SARS-CoV2 positive patients
- Correspondence to Prof Pierre Miossec, Immunology and rheumatology, University of Lyon, Lyon 69007, France; miossec{at}univ-lyon1.fr
Citation
High oligoclonality of immunoglobulins in SARS-CoV2 positive patients
Publication history
- Received June 15, 2020
- Revised July 18, 2020
- Accepted July 31, 2020
- First published August 10, 2020.
Online issue publication
March 06, 2023
Article Versions
- Previous version (3 March 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage